Analyst Rating Divergence: DA Davidson Downgrade vs BofA/Deutsche Bank Upgrades
Key Questions
What recent analyst rating changes have occurred for CoreWeave (CRWV)?
DA Davidson downgraded the stock to Neutral with a $100 price target, while BofA raised its target to $140 and Deutsche Bank issued a Buy rating at $135. Rosenblatt initiated coverage with a Buy rating and $250 price target, the new street high, and Cantor Fitzgerald reiterated Overweight at $167.
What is the consensus analyst recommendation and price target for CRWV?
The consensus rating is Moderate Buy with an average price target of $131.52. Price targets range widely from $100 to $250, reflecting significant dispersion among firms including Bernstein's Sell rating at $67.
Why has CoreWeave stock price reacted to these analyst calls?
The stock surged 10% following NDX inclusion and multiple positive calls from firms like BofA, Deutsche Bank, and Rosenblatt. TipRanks AI has flagged caution amid the mixed views, with some analysts highlighting undervaluation and others noting risks.
DA Davidson downgraded to Neutral/$100 (from Buy/$175). BofA raised PT to $140, Deutsche Bank Buy/$135, GF Buy/$162, 24/7 Wall St. $165.77, BNP Paribas Outperform/$192. Bernstein reiterates Sell/$67 and Underperform with $36-$303 range. SA analyst Oliver Rodzianko downgraded to Sell. TipRanks AI flags caution. Consensus Moderate Buy, PT $131.52. PT dispersion $100-$192. Cantor Fitzgerald reiterates Overweight/$167, calling CRWV 'woefully undervalued' with $125B backlog and 6.2x EV/run-rate EBITDA. Macquarie upgraded to Outperform/$125. A new analyst piece (SpicyTrade) set a $266.78 PT (150% upside) based on EV/S discount vs Nebius and NVIDIA's 11% stake. Stock surged 10% on NDX inclusion and these calls. Today, Cantor Fitzgerald reiterated Overweight/$167. A detailed analysis provides bull/bear cases but no new analyst ratings. Today's new article provides balanced bull/bear analysis with a $105 buy zone. MarketBeat roundup mentions analyst consensus Moderate Buy $132 PT. Today, Rosenblatt initiated coverage with Buy/$250 PT, widening the PT dispersion to $100-$250 and becoming the new street-high.